Transcat, Inc.
corporate_fare Company Profile
Transcat, Inc. (NASDAQ:TRNS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for TRNS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-31, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for TRNS spans 10-Q, 8-K, 144, 10-K.
Recent high-impact activity:
- Transcat Buys Southeastern Biomedical to Expand Calibration Channel
- Transcat Q1 Revenue Jumps 22% but Net Income Halves; Material Weaknesses Persist
- Transcat Q1 FY27: Service Revenue Jumps 27%, Adjusted EBITDA Climbs 19%, and Margins Keep Expanding
- Transcat Q1 Service Revenue Jumps 27%, Gross Margin Expands
- Former CEO Lee Rudow Files Intent to Sell $6.3M in Transcat Stock
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for TRNS, detected from its recent SEC filings.
Resale Registration Filed · Final Holdback Shares Released
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →